Healing bone using recombinant human bone morphogenetic protein 2 and copolymer

Clinical Orthopaedics and Related Research

Volumn 349, Issue , 1998, Pages 205-217

  Kirker Head, Carl A ^a   Gerhart, Tobin N ^b   Armstrong, Rosa ^c   Schelling, Scott H ^a   Carmel, Laura A ^a  

^a TUFTS UNIVERSITY   (United States)

^b Boston Orthopedic Group   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; COPOLYMER; POLYGLACTIN; RECOMBINANT PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE PLATE; BONE RADIOGRAPHY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; FEMUR; FRACTURE HEALING; NONHUMAN; PRIORITY JOURNAL; SHEEP; TREATMENT OUTCOME;

EID: 0031957888     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199804000-00026     Document Type: Article

References (62)

1. Agrawal CM, Best J, Boyan BD, Heckman JD: In vitro protein release characteristics of a bioabsorbable carrier of BMP for fracture non-unions. Trans Orthop Res Soc 19:602, 1994.
2. Alpásian C, Irie K, Takahashi K, et al: Long-term evaluation of recombinant human bone morphogenetic protein-2 induced bone formation with a biologic and synthetic delivery system. Br J Oral Maxillofac Surg 34:414-418, 1996.
3. Bostman O. Hirvensalo E, Makinen J, Rokkanen P: Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers. J Bone Joint Surg 72B:592-595, 1990.
4. Bostman O, Paivarinta U, Manninen M, et al: Polymeric debris from absorbable polyglycolide screws and pins. Acta Orthop Scand 63:555-559, 1992.
5. Bostman O, Paivarinta U, Partio E, et al: Degradation and tissue replacement of an absorbable polyglycolide screw in the fixation of rabbit femoral osteotomies. J Bone Joint Surg 74A:1021-1031, 1992.
6. Bostman O, Partio E, Hirvensalo E, et al: Foreign-body reactions to polyglycolide screws. Acta Orthop Scand 63:173-176, 1992.
7. Bostrom M, Lane JM, Tomin E, et al: Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 327:272-282, 1996.
8. Carlson GP, George LW: Copper Toxicosis. In Smith BP (ed). Large Animal Internal Medicine. St Louis, CV Mosby 1101-1102, 1990.
9. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC: Recombinant human osteogenic protein-1 (RHOP-1) heals segmental long-bone defects in non-human primates. Trans Orthop Res Soc 18:484, 1993.
10. David SM, Gruber HE, Murakami T, et al: Lumbar spinal fusion using recombinant human bone morphogenetic protein (rhBMP-2): A randomized, blinded and controlled study. Trans Orthop Res Soc 21:119, 1996.
11. Einhorn TA: Clinical applications of recombinant gene technology: Bone and cartilage repair. Cells Mater 2:1-11, 1992.
12. Ferguson D, Davis WL, Urist MR, Hurt WC, Allen EP: Bovine bone morphogenetic protein (bBMP) fraction-induced repair of craniotomy defects in the rhesus monkey (macaca speciosa). Clin Orthop 219:251-258, 1987.
13. Finerman GA, Gerth N, Urist M: Synergistic effects of 19K and 22K BMP. Trans Orthop Res Soc 17:70, 1992.
14. Gerhart TN ,Kirker-Head CA, Kriz MJ, et al: Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 293:317-326, 1993.
15. Heckman J, Boyan B, Aufdemorte T, et al: The use of morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg 73A: 750-764, 1991.
16. Hollinger J, Schmitz J, Mark D, Seyfer A: Osseous wound healing with xenogeneic bone implants with a biodegradable carrier. Surgery 107:50-54, 1990.
17. Isobe M, Yamazaki Y, Oida S, et al: Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. J Biomed Mater Res 32:433-438, 1996.
18. Johnson EE, Urist MR, Finerman GAM: Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop 230:257-265, 1988.
19. Johnson EE, Urist MR, Finerman GAM: Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report Clin Orthop 236: 249-257, 1988.
20. Johnson EE, Urist MR, Finerman GAM: Resistant nonunions and partial or complete segmental defects of long bones, Clin Orthop 277:229-237, 1992.
21. Kenley RA, Turek T, Jin L, et al: Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res 28: 1139-1147, 1994.
22. Kim HD, Smith JG, Valentini RF: Bone morphogenetic protein-2 induction of pluripotent C3H10T1/2 cells in porous PLLA scaffolds. Trans Orthop Res Soc 22:546, 1997.
23. Kirker-Head CA: Novel Biological Agents to Enhance Fracture Healing. In Nixon A (ed). Equine Fracture Repair. Philadelphia. WB Saunders 93-103, 1995.
24. Kirker-Head CA: Recombinant human bone morphogenetic proteins: Novel substances for enhancing bone healing. Vet Surg 24:408-419, 1995.
25. Kirker-Head CA: Developing Recombinant Bone Morphogenetic Protein for Clinical Use. In Lindholm TS (ed). Skeletal Reconstruction and Bioimplantation. Georgetown, TX, Landes Bioscience. In press.
26. Kirker-Head CA, Gerhart TN, Armstrong R, Schelling SH, Carmel L: Long-term healing of large midfemoral segmental defects in sheep using recombinant human bone morphogenetic protein 2 and a bioerodible carrier. Scientific Presentation Abstracts-American College of Veterinary Surgeons 29th Annual Meeting. Vet Surg 23:405-406, 1994.
27. Kirker-Head CA, Gerhart TN, Schelling SH, et al: Long-term healing of bone using recombinant human bone morphogenetic protein 2. Clin Orthop 318:222-230, 1995.
28. Kirker-Head CA, Nevins M, Palmer R, Nevins ML, Schelling SH: A new animal model for maxillary sinus augmentation: Evaluation parameters. Int J Oral Maxillofac Implants 12:403-411, 1997.
29. Kleinschmidt J, Marden L, Kent D, et al: A multiphase system bone implant for regenerating the calvaria. Plast Reconstr Surg 91:581-588, 1993.
30. Lee SC, Shea M, Battle MA, et al: Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix. J Biomed Mater Res 28: 1149-1156, 1994.
31. Lianjia Y, Yan J: Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions. Clin Orthop 257:249-256, 1990.
32. Lieberman JR, Le LQ, Stevenson S, et al: In vivo bone induction with BMP producing cell line and a polylactic glycolic acid biodegradable delivery system. Trans Orthop Res Soc 22:251, 1997.
33. Linde A, Hedner E: Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive e-PTFE membranes: An experimental study in rats. Calcif Tissue Int 56:549-553, 1995.
34. Luvten FP, Cunningham NS, Vucicevic S, et al: Advances in osteogenin and related bone morphogenetic proteins in bone induction and repair. Acta Orthop Belg 58(Supp 1):263-267, 1992.
35. Meikle M, Mak W, Papaioannou S, et al: Bone-derived growth factor release from poly(a-hydroxy acid) implants in vitro. Biomaterials 14:177-183, 1993.
36. Meikle M, Papaioannou S, Trevor J, et al: Effect of poly DL-lactide-co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. Biomaterials 15: 513-521, 1994.
37. Miyamoto S, Takaoka K: Bone induction and bone repair by composites of bone morphogenetic protein and biodegradable synthetic polymers. Ann Chir Gynaecol 207(Suppl):69-75, 1993.
38. Miyamoto S, Takaoka K, Hashimoto J, Ono K: A new synthetic biodegradable polymer suitable as a carrier for bone morphogenetic protein. Trans Orthop Res Soc 17:573, 1992.
39. Miyamoto S, Takaoka K, Okada T, et al: Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin Orthop 278:274-285, 1992.
40. Miyamoto S, Takaoka K, Okada T, et al: Polylactic acid-polyethylene glycol block copolymer. A new biodegradable synthetic carrier for bone morphogenetic protein. Clin Orthop 294:333-343, 1993.
41. Muschler GF, Hyodo A, Manning T, Kambic H, Easley K: Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop 308:229-240, 1994.
42. Özkaynak E, Patrick NJ, Oppermann S, et al: Murine osteogenic protein (OP-1): High levels of mRNA in kidney. Biochem Biophys Res Commun 179:116-123, 1991.
43. Paivarinta U, Bostman O, Majola A, et al: Intraosseous cellular response to biodegradable fracture fixation screws made of polyglycolide or polylactide. Arch Orthop Trauma Surg 112:71-74, 1993.
44. Panjabi MM, Walter SD, Karuda M, White AA, Lawson JP: Correlations of radiographic analysis of healing fractures with strength: A statistical analysis of experimental osteotomies. J Orthop Res 3:212-218, 1985.
45. Saitoh H, Takata T, Nikai H, et al: Effect of polylactic acid on osteoinduction of demineralized bone: Preliminary study of the usefulness of polylactic acid as a carrier of bone morphogenetic protein. J Oral Rehabil 21:431-438, 1994.
46. Sampath TK, Maliakal JC, Hauschka PV, et al: Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267:20352-20362, 1992.
47. Sampath TK, Ozkaynak E, Jones W, et al: Recombinant human osteogenic protein (hOP-1) induces new bone formation with a specific activity comparable to that of natural bovine OP. Trans Orthop Res Soc 17:72, 1992.
48. Sandhu HS, Kanim LE, Kaho JM, et al: Evaluation of rhBMP-2 with an OPLA carrier in canine posterolateral (transverse process) spinal fusion model. Spine 20:2669-2682, 1995.
49. Schenk RK, Hunziker EB: Histologic and Ultra-structural Features of Fracture Healing. In Brighton CT, Friedlaender G, Lane JM (eds). Bone Formation and Repair. Rosemont, IL, American Academy of Orthopaedic Surgeons 125-133, 1994.
50. Schmitz JP, Hollinger JO: The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop 205:299-308, 1986.
51. Sela J, Applebaum J, Uretzkv G: Osteogenesis induced by bone matrix is inhibited by inflammation. Biomater Med Devices Artif Organs 14:227-237, 1988.
52. Shetty V, Kossovsky N: The ultrastructural architecture of the tissue/hard-tissue replacement interface. J Oral Maxillofac Surg 50:384-385, 1992.
53. Sigurdsson TJ, Lee MB, Kubota K, et al: Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 66:131-138, 1995.
54. Smith JL, Jin L, Parsons T, et al: Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein 2 (rhBMP-2). J Control Rel 36:183-195, 1995.
55. Strong MD, Savers MH, Conrad EU: Screening Tissue Donors for Infectious Markers. In Friedlaender GE, Goldberg VM (eds). Bone and Cartilage Allografts. Park Ridge, IL, American Academy of Orthopedic Surgeons 193-211, 1989.
56. Takaoka K, Koezuka M, Nakahara H: Telopeptidedepleted bovine skin collagen as a carrier for bone morphogenetic protein. J Orthop Res 9:902-907, 1991.
57. Wang EA, Rosen V, D'Alessandro J, et al: Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220-2224, 1990.
58. Wang EA, Rosen V, Cordes P, et al: Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 85:9484-9488, 1988.
59. Winet H, Hollinger JO: Incorporation of polylactide-polyglycolide in a cortical defect: Neoosteogenesis in a bone chamber. J Biomed Mater Res 27:667-675, 1993.
60. Wozney JM, Rosen V, Celeste AJ, et al: Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534, 1988.
61. Yabu M, Takaoka K, Hashimoto J, et al: Ultramicroscopic aspects of the conversion of fibroblasts to chondrocytes in the mouse dorsal subfascia induced by bone morphogenetic protein (BMP). Arch Histol Cytol 54:95-102, 1991.
62. Yamazaki Y, Oida S, Ishihara K, et al: Ectopic induction of cartilage and bone by bovine bone morphogenetic protein using a biodegradable polymeric reservoir. J Biomed Mater Res 30:1-4, 1996.